⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IRD News
Opus Genetics, Inc. Common Stock
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
IRD
Opus Genetics Featured on Good Morning America Spotlighting Breakthrough Gene Therapy Restoring Sight in Patients with Inherited Blindness
globenewswire.com
IRD
Opus Genetics to Participate in Chardan's 9th Annual Genetic Medicines Conference
globenewswire.com
IRD
Opus Genetics to Present at Upcoming Medical and Industry Conferences in October 2025
globenewswire.com
IRD
Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)
globenewswire.com
IRD